Lumibird announces the launch by Lumibird Medical of C.DIAG, a new-generation AI-enabled dry eye diagnostic platform. This Europe-wide launch follows the CE marking certified by LNE-GMED on April 30.

This product integrates the C.SUITE offering, which covers dry eye diagnosis, treatment and patient education, and positions Lumibird Medical as a unique player in a market estimated to be worth $6.4 billion by 2024.

In the global dry eye market, the share dedicated to medical devices is growing fastest, with an estimated increase of over 20% by 2026", points out Delphine Southon, Product Manager for the dry eye range.

Copyright (c) 2024 CercleFinance.com. All rights reserved.